18.2.2022
Two million euros for XO Life's patient insights platform
The international Healthcare VC SeedLink, the corporate VC MediVentures of the pharmaceutical company MEDICE and other investors are taking part.
The medtech start-up XO Life, based in Berlin and Munich, raised more than 2 million euros to further develop its patient insights platform for drugs and therapies, which the company has developed from a leading reporting and information platform for side effects. The patient insights platform enables patients to record their own experiences with their health status, medications and illnesses, so-called patient-reported outcomes (PRO), in a standardized and privacy-compliant manner. The experiences can be compared with other users and transmitted anonymously to the healthcare industry to further develop their products and improve their therapies.
Would you like to find out more or are you interested in XO Life?
Get in touch now, get a demo or answer individual questions in a personal conversation.
XO Life News
Discover even more news
medac and XO Life implement cooperation for digital therapy support in uro-oncology
medac and XO Life have developed innovative digital product and therapy support for one of the most important urological medac products.
XO Life is among the top 5% of the top-rated companies on kununu
XO Life uses an outstanding team culture, remote work and team spirit to be one of the highest rated startups on kununu.
XO Life: From German Startup to Pioneer Across Europe
XO Life stands out as a digital pioneer by supporting precision medicine through the use of patient-reported results.